DOC — Healthpeak Properties, Inc. stock price, charts and financials

QT58Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (NYSE: DOC) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
21.62
-0.02-0.09%
OverviewShort InterestFilings
DOCQT58Healthpeak Properties, Inc.·NYSE
21.62-0.09%
TA
Loading chart...
Screen all →
OHI-0.55%$48.74AHR-1.18%$54.47CTRE-0.92%$40.84HR-1.31%$20.27SBRA+0.24%$20.66VTR+0.00%$90.85NHI-1.82%$74.56MPW+0.00%$5.50
Snapshot
IndexS&P 500P/E67.56EPS (ttm)0.32Insider Own0.91%Shs Outstand689.42MPerf Week-5.26%
Market Cap14.91BForward P/E-EPS next Y0.10Insider Trans-0.18%Shs Float686.65MPerf Month-0.60%
Enterprise Value24.45BPEG-EPS next Q-Inst Own-Short Float3.49%Perf Quarter32.72%
Income223.00MP/S5.19EPS this Y3.02%Inst Trans-Short Ratio2.81Perf Half Y27.78%
Sales2.87BP/B1.65EPS next Y-70.75%ROA1.03%Short Interest23.95MPerf YTD34.45%
Book/sh13.10P/C12.73EPS next 5Y-ROE2.88%52W High22.95 -5.80%Perf Year28.92%
Cash/sh1.70P/FCF12.73EPS past 3/5Y-52.28% -33.52%ROIC16.24%52W Low15.70 37.71%Perf 3Y-0.51%
Dividend Est.0.41 (1.88%)EV/EBITDA13.70Sales past 3/5Y11.06% 11.41%Gross Margin1.89%Volatility2.38% 2.00%Perf 5Y-41.52%
Dividend TTM1.22 (5.64%)EV/Sales8.51EPS Y/Y TTM-11.11%Oper. Margin18.31%ATR (14)0.47Perf 10Y-44.68%
Dividend Ex-DateAug 17, 2026Quick Ratio2.02Sales Y/Y TTM6.37%Profit Margin7.73%RSI (14)47.99Recom2.49
Dividend Gr. 3/5Y-9.76% -10.88%Current Ratio2.02EPS Q/Q-39.13%SMA20-2.03%Beta0.98Target Price22.14
Payout381.55%Debt/Eq1.26Sales Q/Q7.11%SMA502.70%Rel Volume0.89Prev Close21.64
Employees411LT Debt/Eq1.26EarningsOct 22SMA20018.36%Avg Volume8.17MPrice21.62
IPO DateMay 23, 1985Option/ShortYes / YesEPS/Sales Surpr.430.66% 6.36%Net Debt/EBITDA5.35Volume7,269,110Change-0.09%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-15-26ReiteratedWells FargoEqual Weight$18 → $22
Jul-07-26DowngradeBarclaysOverweight → Equal Weight$20 → $23
Jul-06-26ReiteratedMizuhoOutperform$24
Jun-15-26ReiteratedBMO CapitalOutperform$24
Jun-11-26DowngradeMorgan StanleyOverweight → Equal Weight$20 → $22
May-27-26ReiteratedScotiabankSector Perform$21
May-22-26ReiteratedMorgan StanleyOverweight$18 → $20
May-13-26ReiteratedUBSNeutral$17 → $19
Apr-28-26ReiteratedMorgan StanleyOverweight$21 → $18
Apr-20-26InitiatedUBSNeutral$17
Latest News
Aug-04-26
Aug-04-2606:41PM
Healthpeak (DOC) Surpasses Q2 FFO and Revenue Estimateszacks.com
04:30PM
Is Healthpeak Properties Inc (DOC) Fairly Valued After Q2 Earnings Beat? EPS at $0.08, Revenue at $771.58 Million -- GF Score: 79/100gurufocus.com
04:15PM
Healthpeak Properties Reports Second Quarter 2026 Results and Increases Full Year 2026 Earnings Guidancebusinesswire.com
Jul-30-26
Jul-30-2611:50AM
Healthpeak Properties (NYSE:DOC) Flashing Perfect Breakout Setup with Top Technical RatingsChartMill
Jul-29-26
Jul-29-2602:21PM
What's in the Cards for Healthpeak Properties This Earnings Season?zacks.com
Jul-26-26
Jul-26-2609:00AM
The Fed's Crude DilemmaSeekingAlpha
Jul-25-26
Jul-25-2608:45AM
5 Monthly Dividend Stocks Paying Up To 18.2%forbes.com
Jul-21-26
Jul-21-2605:51PM
Healthpeak & Brookfield Form Outpatient Medical Joint VentureYahoo
Jul-20-26
Jul-20-2606:45AM
Healthpeak Properties and Brookfield Form a $2.1 Billion Strategic Joint Venturebusinesswire.com
Jul-17-26
Jul-17-2610:00AM
3 Healthcare REITs to Buy as America Ages in July247wallst.com
Jul-16-26
Jul-16-2609:00AM
Top 10 Dividend Stocks to Buy in 2026youtube.com
Jul-14-26
Jul-14-2612:14PM
Healthpeak Properties' Q2 2026 Earnings: What to ExpectYahoo
Jul-09-26
Jul-09-2604:15PM
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Third Quarter of 2026businesswire.com
Jul-07-26
Jul-07-2606:17PM
Janus Living: The Pure Play On Senior Housing GrowthSeekingAlpha
Jul-03-26
Jul-03-2609:15AM
3 REITs to Buy for Passive Income in July247wallst.com
Company

Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,8722,8232,7002,1812,0611,8961,6451,2401,191
Cost of Goods Sold Incl. D&A2,8182,1881,075902863773783405379
Gross Profit556351,6261,2791,1981,123862835813
Selling, General and Administrative Excl. Other9090979513198939397
Research and Development
000000000
Other Operating Expense-56101,057750711685554435404
Operating Income526544471434357340215307311
Interest Expense320305280200173158218218261
Unusual Expense
—————————
Non-Operating Income (Expense)52-1298192325-4815481783
Net Income Before Taxes258110272325509134151170833
Income Taxes794-10-4-3-9-5-4
Consolidated Net Income22371243306500506414461,061
Net Income From Continuing Operations251101267335514138161175837
Net Income22371243306500506414461,061
EPS (Recurring)0.320.100.360.560.920.930.770.092.25
EPS (Basic, Before Extraordinaries)0.320.100.360.560.920.930.770.092.25
EPS (Diluted)0.320.100.360.560.920.930.770.092.24
EBITDA1,7841,4741,6111,2651,3919711,1331,0541,649
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio67.56160.8056.3135.3627.2538.8139.26383.0012.47
Price To Sales Ratio5.233.965.084.976.5610.269.7613.5111.05
Gross Margin1.9222.4960.2258.6458.1359.2352.4067.3468.26
Operating Margin18.3119.2717.4419.9017.3217.9313.0724.7626.11
Net Margin7.762.529.0014.0324.2626.6925.173.7189.08
Shares Outstanding695696676547539539531486471
Market Capitalization15,02611,19213,70310,83113,51319,45316,05216,75213,155
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$23.88$21.59$19.30$17.01$14.72● Close Price0.00K53.44K106.87K160.31K213.74KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Bohn Scott RCDO and Head of LabMay 12 '26Sale19.4510,989213,7407,636May 13
Thomas John TDirectorAug 06 '25Buy17.051,45024,730810,016Aug 06
Brinker Scott MPresident and CEOAug 04 '25Buy16.831,49025,077211,906Aug 04
Brinker Scott MPresident and CEOJul 31 '25Buy17.062,93049,986210,416Jul 31
Brinker Scott MPresident and CEOJul 28 '25Buy17.402,87349,990207,486Jul 29
Thompson Tommy GDirectorMay 28 '25Buy17.275,77799,769144,290May 28
Thompson Tommy GDirectorMay 09 '25Buy17.365,70098,974138,513May 12
Brinker Scott MPresident and CEOMay 09 '25Buy17.392,75047,823204,613May 12
Lias-Booker AvaDirectorApr 29 '25Buy17.835,00089,15035,561Apr 29
Thomas John TDirectorApr 28 '25Buy17.844,20074,928813,566Apr 28
Sandstrom Katherine MDirectorApr 28 '25Buy17.6511,288199,23356,268Apr 28
Lewis Sara GrootwassinkDirectorApr 28 '25Buy17.666,000105,9389,000Apr 28
SHELLEY-KESSLER PAMELADirectorApr 28 '25Buy17.612,83849,9913,965Apr 28
Brinker Scott MPresident and CEOApr 28 '25Buy17.6811,337200,438201,863Apr 28
Lewis Sara GrootwassinkDirectorMar 04 '24Buy16.7118,000300,78022,000Mar 04
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.